Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2015   |   Volume: 4   |   Issue: 3   |   Page: 422-424     View issue
An unusual case of masquerading malignant melanoma
Saurabh Samdariya, Dewesh Kumar, Chendil Vishwanathan, Iqbal Ahmed

Metastatic malignant melanoma is an aggressive rare skin cancer with fatal outcomes. Sole of the foot is often a lately identified site and misdiagnosed with other skin pathologies. We present a middle-aged male diagnosed with malignant melanoma of sole of the foot with extensive distant metastasis. He presented to the hospital with the complaints of enlarged inguinal lymph node. He was unaware of the lesion present on sole of the foot till it was diagnosed. Educational activities for health professionals and awareness programs for public are present day′s need for identification of this disease in its early stage to enhance the possibilities of cure.

Fatal, foot, malignant melanoma, metastatic disease

INTRODUCTION

Metastatic malignant melanoma is considered the most aggressive form of skin cancer with a median overall survival of less than a year. [1] Despite being an uncommon form of skin cancer, it results in the majority of skin cancer deaths. [2] Mortality and morbidity remain high in older adults, [3] males, [4] less affluent [5] and less well-educated people. [6] Foot is the primary site of involvement in approximately 3-15% of all cutaneous malignant melanoma. [7] Malignant melanoma of the foot holds a poorer prognosis than melanoma elsewhere. [8] A lesion on the face is likely to result in prompt action by the patient and practitioner than one on the foot; consequently a delayed presentation results in thicker and more advanced tumors. Additionally foot melanoma, possibly because of its rarity, is frequently misdiagnosed with common foot disorder such as tinea pedis, onychomycosis, warts, hematoma, and paronychia, in growing toe nail, blisters, ganglions and callus. Misdiagnosis rates for melanoma of the foot have been reported to be between 25% and 66% [6],[9] compared with much lower rates of 12-16% for melanoma at other sites. [10] We report a case of malignant melanoma of the foot who had widespread metastatic disease on presentation.

CASE REPORT

A 45-year-old male, mechanic by occupation, known diabetic and hypertensive from Bengaluru (Karnataka, India) reported to the Department of Radiotherapy, Victoria Hospital, with chief complaints of swelling in right groin since 3 months and swelling of right lower limb since 15 days. Patient was shown to a local practitioner and biopsy of the groin mass was done, which revealed metastatic deposits showing poorly differentiated carcinoma and patient was referred to for further management. On evaluating detailed history of patient revealed that he underwent surgical excision of a small black colored skin thickening of sole of right foot 1-year back, which reappeared 6 months thereafter with bigger size and accompanying similar black colored smaller skin thickenings around the previous skin lesion.

On examination, there was a matted lymph nodal mass measuring approximately 13 cm × 14 cm present in right inguinal region. On careful examination, a black color papule measuring approximately 1.5 cm × 1.5 cm was found on sole of the right foot at the site of calcaneum process [Figure 1]. There were five sub-centimetric satellite lesions noted around the papule [Figure 2].{Figure 1}{Figure 2}

Patient was evaluated by biopsy of inguinal lymph node which showed a poorly differentiated tumor with melanin pigment [Figure 3]. Further immunohistochemistry study of the biopsy sample showed neoplastic cells positive for Melan-A, HMB-45 [Figure 4], Vimentin, focally for S-100 and negative for LCA, CD20, CK, synaptophysin, CD3. Then a diagnosis of melanoma of sole of the foot was made, and patient was further evaluated for visceral metastasis. Bone marrow biopsy was positive for metastatic deposits of malignant melanoma. Contrast-enhanced computed tomography scan of abdomen and pelvis revealed multiple bulky non enhancing nodes in paraaortic, aortocaval group encasing aorta, and inferior mesenteric artery [Figure 5]. It also revealed multiple mediastinal hilar lymph nodes in the chest and multiple focal hypodense nodules of varying sizes in both lobes of the liver [Figure 6] and bilateral lungs. A small hypodense nodule in left adrenal gland and sclerotic bone lesion in T7 vertebra suggesting metastatic lesion were seen.

Hence, a final diagnosis of malignant melanoma of sole of the foot with distant metastasis was made. Patient and his relatives were counseled regarding metastatic nature of the disease and poor prognosis associated with it. Despite all therapeutic measures patient′s disease progressed, and he died of multiorgan failure after 4 months of presentation.{Figure 3}{Figure 4}{Figure 5}{Figure 6}

DISCUSSION

Malignant melanoma is the most aggressive skin cancer associated with fatal outcomes. Melanoma affecting sole of the foot has a poorer prognosis than other sites of the body. [8] This may be due to delayed detection of abnormality by patient and medical practitioner. Delayed presentation of these lesions results in thicker and more advanced tumors. Secondly, foot melanoma, possibly because of its rarity, is frequently misdiagnosed as a more common benign foot disorder.

The rapid fatal outcome of our patient within 1-year shows the rapid progressive nature of this disease. Associated diabetes mellitus in our patient also made him more immunosuppressed leading to further accelerating the progression of melanoma. Patient′s negligence and medical practitioner misdiagnosis are also contributing factor in the progression of the disease.

The rapidly progressing course of this disease can be counteracted by its early diagnosis and treating it in early stages. Bristow et al. has described clinical guidelines for the recognition of melanoma of the foot and nail unit. [11] Early diagnosis of this disease can be achieved by increasing awareness among public and training of medical practitioners.

CONCLUSION

Malignant melanoma of the foot can be considered as a differential diagnosis in small papular skin lesions found on foot. Health care programs should be undertaken actively to spread awareness about these types of rare and fatal cancers.

ACKNOWLEDGMENT

Dr. Heena Kauser for technical help.

References

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.

UK Skin Cancer Mortality Statistics. Available from: [Last accessed on 15 Jan 2015].

Payette MJ, Katz M 3 rd , Grant-Kels JM. Melanoma prognostic factors found in the dermatopathology report. Clin Dermatol 2009;27:53-74.

Downing A, Yu XQ, Newton-Bishop J, Forman D. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003. Int J Cancer 2008;123:861-6.

Ortiz CA, Goodwin JS, Freeman JL. The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma. Med Sci Monit 2005;11:RA163-72.

Baumert J, Plewig G, Volkenandt M, Schmid-Wendtner MH. Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol 2007;156:938-44.

Bennett DR, Wasson D, MacArthur JD, McMillen MA. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot. J Am Coll Surg 1994;179:279-84.

Hsueh E, Lucci A, Qi K, Morton D. Survival of patients with melanoma of the lower extremity decreases with distance from the trunk. Cancer Causes Control 1998;85:383-8.

Bristow I, Acland K. Acral lentiginous melanoma of the foot: A review of 27 cases. J Foot Ankle Res 2008;1:11.

Osborne JE, Bourke JF, Graham-Brown RA, Hutchinson PE. False negative clinical diagnoses of malignant melanoma. Br J Dermatol 1999;140:902-8.

Bristow IR, de Berker DA, Acland KM, Turner RJ, Bowling J. Clinical guidelines for the recognition of melanoma of the foot and nail unit. J Foot Ankle Res 2010;3:25.

© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513